SLECTRIV
LIVE

Serial Number

79201837

Owner

NOVARTIS AG

Filing Date

Jun 30, 2016

Add to watchlist:

No watchlists yet
View on USPTO

SLECTRIV Trademark

Serial Number: 79201837 • Registration: 5225611

SLECTRIV is a trademark filed by NOVARTIS AG on June 30, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

June 30, 2016

Registration Date

June 20, 2017

Published for Opposition

April 4, 2017

Cancellation Date

January 5, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceutical products; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Nov 17, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 12, 2024 INTS
INVALIDATION PROCESSED
Sep 12, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 6, 2024 INTR
CANCELLED SECTION 71
Jan 5, 2024 C71T
NOTIFICATION PROCESSED BY IB
Oct 13, 2017 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jul 28, 2017 FICS
FINAL DISPOSITION PROCESSED
Jul 28, 2017 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jul 20, 2017 GPAR
REGISTERED-PRINCIPAL REGISTER
Jun 20, 2017 R.PR
PUBLISHED FOR OPPOSITION
Apr 4, 2017 PUBO
NOTICE OF PUBLICATION
Mar 15, 2017 NPUB
APPLICATION FILING RECEIPT MAILED
Feb 28, 2017 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 23, 2017 CNSA
ASSIGNED TO EXAMINER
Feb 22, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 22, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 17, 2017 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Feb 16, 2017 SDRC